for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

AstraZeneca's cancer drug fails to meet main goal in COVID-19 study

Nov 12 (Reuters) - AstraZeneca PLC said on Thursday its cancer treatment, Calquence, failed to meet the main goal of a mid-stage trial, testing it in patients hospitalized with respiratory symptoms of COVID-19. (Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Anil D’Silva)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up